letibotulinumtoxinA-wlbg

CHEBI:CHEBI_747120

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_start_date
20240730
package_marketing_start_date
20240730
pharm_class_pe
Neuromuscular Blockade [PE]
pharm_class
Acetylcholine Release Inhibitors [MoA]
marketing_category
BLA
nui
N0000175770
pharm_class_epc
Neuromuscular Blocker [EPC]
pharm_class_moa
Acetylcholine Release Inhibitors [MoA]
generic_name
letibotulinumtoxinA-wlbg
brand_name
LETYBO
brand_name_base
LETYBO
product_ndc
81165-100
application_number
BLA761225
labeler_name
Hugel, Inc.
manufacturer_name
Hugel, Inc.
spl_id
2784ba3d-d3f8-1059-e063-6394a90a2ff1
active_ingredient_name
LETIBOTULINUMTOXINA
active_ingredient_strength
100 U/1
package_ndc
81165-100-01
package_description
1 VIAL, SINGLE-DOSE in 1 CARTON (81165-100-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
rxcui
2689301
unii
W5O50S8A59
spl_set_id
910e5d0e-4d0b-4de8-8e2d-97879a044181
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class